Affiliation: Foundation ResearchLecturer in Cancer Biology, Discipline of Biochemistry, NUI, Galway, Director Blood Cancer Network Ireland, Director Blood Cancer Biobank Ireland, Principal investigator Cancer Niche Laboratory. Career information Dr. Szegezdi received her PhD in medical science in 2000 studying cell death signalling at the University of Debrecen, Hungary. She then joined the Cell Stress and Apoptosis Research laboratory led by Prof. Afshin Samali at the National University of Ireland, Galway in 2001 to study stress-induced cell death in heart and pancreatic cells. In 2010 she established her own research group as a Science Foundation Ireland Starting Investigator (SIRG) and an Irish Cancer Society Research Fellow focusing on how the tissues surrounding cancer cells protect the tumour from chemotherapeutics. She took up a university lecturer position in the Discipline of Biochemistry, National University of Ireland, Galway in 2011. In 2017, she received a Research Lectureship position in Cancer Biology,a position she currently holds. Shedirects the Masters degree programme on cancer research, co-PI in the Centre for Research Training in Genomics Data Science and co-ordinates the H2020-funded INTEGRATE programme within the Genomics CRT. Research and Clinical Interests:Research in Dr Szegezdis laboratory focuses on death receptor signal transduction and how death receptor signalling shapes the interaction between the tumour and its microenvironment. In this research, she co-ordinates the H2020-RISE research consortium, DISCOVER. The other research area of her laboratory is blood caner research, especially acute myeloid leukemia and the mechanism of drug resistance mediated by the bone marrow stroma, where AML cells reside. In this research, she directs the national research consortium, Blood Cancer Network Ireland and has established and leads a national biobank collecting blood cancer patient samples.